advantage vet. til hunde (4-10 kg) 100 mg/ml kutanopløsning
bayer animal health gmbh - imidacloprid - kutanopløsning - 100 mg/ml
amaryl 3 mg tabletter
sanofi a/s - glimepirid - tabletter - 3 mg
briotril 400 ec emulsionskoncentrat
adama northern europe b.v. - ioxynil, bromoxynil - emulsionskoncentrat - 160 g/l ioxynil ; 240 g/l bromoxynil
duotril 400 ec emulsionskoncentrat
adama northern europe b.v. - ioxynil, bromoxynil - emulsionskoncentrat - 160 g/l ioxynil ; 240 g/l bromoxynil
glyphogan vandopløseligt koncentrat
adama northern europe b.v. - glyphosat - vandopløseligt koncentrat - 360 g/l glyphosat
goliath suspensionskoncentrat
adama northern europe b.v. - metamitron - suspensionskoncentrat - 700 g/l metamitron
skater suspensionskoncentrat
adama northern europe b.v. - metamitron - suspensionskoncentrat - 700 g/l metamitron
mirador 250 sc suspensionskoncentrat
adama northern europe b.v. - azoxystrobin - suspensionskoncentrat - 250 g/l azoxystrobin
rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - arthritis, reumatoid - immunosuppressiva - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
biobor 150 flydende middel
bionutria danmark aps - bor - flydende middel - 150 g/l bor